Global Bariatric Surgery Market 2024-2032
Market Outlook
Based on Triton’s research report, the global bariatric surgery market is estimated to advance with a CAGR of 5.43% during the forecast years 2024-2032.
The growth of the bariatric surgery market is primarily driven by rising obesity rates globally, increasing awareness about the health risks associated with obesity, advancements in surgical techniques making procedures minimally invasive, safer, and effective, and fostering greater accessibility for patients seeking treatment.
On the contrary, the market of bariatric surgery is restricted by factors such as limited insurance coverage, high costs of procedures, surgical risks, and post-operative complications. Additionally, social stigmas surrounding obesity and a lack of awareness about surgical options challenge the market’s progress.
Regional Outlook
The global bariatric surgery market covers Latin America, Europe, Asia-Pacific, North America, and the Middle East and Africa regions.
The Asia-Pacific bariatric surgery market is experiencing robust growth driven by rising obesity rates in countries like India, Japan, South Korea, etc., several technological advancements in bariatric surgeries, supportive government policies, and increasing healthcare infrastructure. Together, these factors lead to the growing adoption of bariatric surgeries.
Competitive Outlook
The major market players in the bariatric surgery market are B. Braun Melsungen AG, Johnson & Johnson, Olympus Corporation, Apollo Endosurgery Inc, Intuitive Surgical Inc, Mediflex Surgical Products, Medtronic Plc, CONMED Corporation, USGI Medical Inc, and AbbVie Inc.
B. Braun Melsungen AG holds a firm position within healthcare solutions, with a legacy of expertise since 1839. With a comprehensive grasp of user requirements, the company offers a diverse array of 5,000 products, 95% of which are crafted in-house. By delivering additional services and consultancy, the company serves as a system provider dedicated to crafting optimal solutions for patients and driving forward medical progress.